{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:28:33Z","timestamp":1793640513695,"version":"4.5.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":250,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02758","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:21:02Z","timestamp":1788996062000},"page":"e02758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Challenges in causality assessment of renal dysfunction during sequential treatment for presumed rifampicin-resistant tuberculosis in an elderly patient"],"prefix":"10.1016","volume":"46","author":[{"given":"Thi Thanh Thuy","family":"Hoang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Chinh","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thien Huong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew James","family":"Codlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan Nguyen Quang","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.idcr.2026.e02758_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2213-2600(20)30047-3","article-title":"Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"8","author":"Lan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.idcr.2026.e02758_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-14-23","article-title":"Acute kidney injury due to anti-tuberculosis drugs: a five-year experience in an aging population","volume":"14","author":"Chang","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02758_bib3","first-page":"941","article-title":"Drug-induced acute kidney injury: diverse mechanisms of tubular injury","volume":"14","author":"Perazella","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.idcr.2026.e02758_bib4","series-title":"WHO consolidated guidelines on tuberculosis: module 4 \u2013 treatment: drug-resistant tuberculosis","author":"World Health Organization","year":"2025"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02758_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.idcr.2026.e02758_bib6","series-title":"The use of the WHO-UMC system for standardised case causality assessment","author":"World Health Organization","year":"2013"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02758_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","article-title":"Methods for causality assessment of adverse drug reactions: a systematic review","volume":"31","author":"Agbabiaka","year":"2008","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02758_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/toxres\/tfae119","article-title":"Drug-induced kidney injury: challenges and opportunities","volume":"13","author":"Connor","year":"2024","journal-title":"Toxicol Res"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02758_bib9","first-page":"463","article-title":"Biomarkers of drug-induced kidney injury","volume":"23","author":"Redahan","year":"2017","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02758_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mayocp.2017.08.024","article-title":"Clinical manifestations and outcomes of fluoroquinolone-related acute interstitial nephritis","volume":"93","author":"Farid","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.idcr.2026.e02758_bib11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02758_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1901814","article-title":"Treatment of highly drug-resistant pulmonary tuberculosis","volume":"382","author":"Conradie","year":"2020","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.idcr.2026.e02758_bib13","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang'wa","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02758_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00907-19","article-title":"Population pharmacokinetics of the antituberculosis agent pretomanid","volume":"63","author":"Salinger","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02758_bib16","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02758_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s43441-023-00599-x","article-title":"Detection, monitoring, and mitigation of drug-induced nephrotoxicity: a pragmatic approach","volume":"58","author":"Antognini","year":"2024","journal-title":"Ther Innov Regul Sci"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02758_bib18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/civ1223","article-title":"Xpert MTB\/RIF results in patients with previous tuberculosis: can we distinguish true from false-positive results?","volume":"62","author":"Theron","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02758_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.diagmicrobio.2016.01.009","article-title":"False-positive rifampin-resistant results with Xpert MTB\/RIF version 4 assay in clinical samples with a low bacterial load","volume":"85","author":"Ocheretina","year":"2016","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:57:54Z","timestamp":1793638674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"alternative-id":["S2214250926002714"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02758","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in causality assessment of renal dysfunction during sequential treatment for presumed rifampicin-resistant tuberculosis in an elderly patient","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02758"}}